Tilray (TLRY) Stock Jumps Despite a Slew of Analyst Price Target Cuts

Tilray (TLRY) stock was up on Thursday after the Canadian cannabis company was hit with a handful of price target cuts from analysts. These followed the company’s latest earnings report, which came out yesterday.

Let’s jump into the analysts’ ratings and price target updates for TLRY stock below.

• Alliance Global Partners analyst Aaron Grey reiterated a Hold rating and cut his price target to $7 from $9, representing a potential 18.04% upside for the shares.
• Four-star Canaccord Genuity analyst Kenric Tyghe maintained a Hold rating and lowered his price target to $6.84 from $9.36, suggesting a 15.31% upside for the shares.
• ATB Cormark Capital analyst Frederico Gomes kept a Hold rating and decreased his price target to $9 from $9.50, implying a 51.77% upside for the shares.
• Roth MKM analyst Bill Kirk upgraded TLRY stock to a Buy rating from a Hold rating and set a Street-high $10 price target, representing a potential 68.63% upside for the shares.

Tilray stock received these price cuts despite its strong performance yesterday. The company beat Wall Street’s earnings per share and revenue estimates for its fiscal third quarter of 2026. It also provided investors with updated guidance for fiscal 2026.

Tilray Stock Movement Today

Tilray stock was up 3.75% today but was still down 29.35% year-to-date. The shares have also fallen 0.63% over the past 12 months.

TLRY stock movement today saw some 2.44 million shares change hands, which was above the company’s three-month average daily trading volume of about 2.39 million shares.

Is Tilray Stock a Buy, Sell, or Hold?

Turning to Wall Street, the analysts’ consensus rating for Tilray is Moderate Buy, based on two Buy and four Hold ratings over the past three months. With that comes an average TLRY stock price target of $7.97, representing a potential 24.4% upside for the shares.